Skip to main content

Advertisement

Log in

Fungating and Ulcerating Breast Cancer: Wound Closure Algorithm, Complications, and Survival Trends

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Fungating breast cancer severely affects patients’ daily lives, and patient management poses major oncology challenges. To present 10-year outcomes of unique tumor presentation, suggesting a focused algorithm for surgical management and providing deep analysis for factors affecting survival and surgical outcomes. Eighty-two patients with fungating breast cancer were enrolled in the period from January 2010 to February 2020 in the Mansoura University Oncology Center database. Epidemiological and pathological characteristics, risk factors, different surgical treatment techniques, and surgical and oncological outcomes were reviewed. Preoperative systemic therapy was used in 41 patients, with the majority (77.8%) showing progressive response. Mastectomy was performed in 81 (98.8%) patients, with primary wound closure in 71 (86.6%), and wide local excision in a single patient (1.2%). Different reconstructive techniques in non-primary closure operations were used. Complications were reported in 33 (40.7%) patients, of which 16 (48.5%) were of Clavien-Dindo grade II category. Loco-regional recurrence occurred in 20.7% of patients. The mortality rate during follow-up was 31.7% (n = 26). Estimated mean overall survival (with 95% CI) was 55.96 (41.98–69.9) months; estimated mean loco-regional recurrence-free survival (with 95% CI) was 38.01 (24.6–51.4) months. Surgery is a cornerstone fungating breast cancer treatment option, but at the expense of high morbidity. Sophisticated reconstructive procedures may be indicated for wound closure. A suggested algorithm based on the center’s experience of wound management in difficult mastectomy cases is displayed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

All the clinical, radiological, and pathological data used in this manuscript is available on Mansoura University medical system (Ibn Sina Hospital Management System). http://srv137.mans.edu.eg/mus/newSystem/

References

  1. Forouzanfar MH, Foreman KJ, Delossantos AM et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (London, England) 378(9801):1461–1484

    Article  PubMed  Google Scholar 

  2. Valero VV, Buzdar AU, Hortobagyi GN (1996) Locally advanced breast cancer. Oncologist 1(1 & 2):8–17

    Article  CAS  PubMed  Google Scholar 

  3. Bogusevicius A, Cepuliene D, Sepetauskiene E (2014) The integrated evaluation of the results of oncoplastic surgery for locally advanced breast cancer. Breast J 20(1):53–60

    Article  PubMed  Google Scholar 

  4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet (London, England) 365(9472):1687–1717

    Article  Google Scholar 

  5. Siegel RL, Miller KD, Jemal A, Cancer statistics (2015) CA: a Cancer. J Clin 65(1):5–29

    Article  Google Scholar 

  6. Beh SY, Leow LC (2016) Fungating breast cancer and other malignant wounds: epidemiology, assessment and management. Exp Rev Quality Life Cancer Care 1(2):137–144

    Article  Google Scholar 

  7. Coebergh JW, Jansen-Heijnen ML, Louwman WJ, ACV (2001) Cancer incidence and survival in the South of the Netherlands, 1955–1999 and incidence in the North of Belgium, 1996–1998. Eindhoven, the Netherlands: Compr Cancer Centre S (IKZ).

  8. Wieland AW, Louwman MW, Voogd AC, van Beek MW, Vreugdenhil G, Roumen RM (2004) Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J Mar-Apr 10(2):123–128

    Article  Google Scholar 

  9. Jarvis V (2014) The range and role of palliative interventions for locally advanced breast cancer. Curr Opin Support Palliat Care 8(1):70–76

    Article  PubMed  Google Scholar 

  10. Bottomley A, Therasse P, Piccart M et al (2005) Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial. Lancet Oncol 6(5):287–294

    Article  PubMed  Google Scholar 

  11. Tryfonidis K, Senkus E, Cardoso MJ, Cardoso F (2015) Management of locally advanced breast cancer-perspectives and future directions. Nature Rev. Clin Oncol 12(3):147–162

    Article  Google Scholar 

  12. Chia D, Tan EY, Lu J et al (2016) Clinical outcomes of fungating breast cancer treated with palliative radiotherapy. J Radiat Oncol 5(4):411–416

    Article  CAS  Google Scholar 

  13. Seaman S (2006) Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs 22(3):185–193

    Article  PubMed  Google Scholar 

  14. S T (1992) Current practices in the management of fungating lesions and radiotherapy damaged skin. Bridgend, Mid Glamorgan: The Surgical Materials Testing Laboratory

  15. Probst S, Arber A, Faithfull S (2009) Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs: Off J Eur Oncol Nurs Soc 13(4):295–298

    Article  Google Scholar 

  16. Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast (Edinburgh, Scotland) 15(3):399–409

    Article  CAS  PubMed  Google Scholar 

  17. Kumar A, Shah LL, Khanna S, Khanna NN (1987) Preoperative chemotherapy for fungating breast cancer. J Surg Oncol 36(4):295–298

    Article  CAS  PubMed  Google Scholar 

  18. Grocott P, Cowley S (2001) The palliative management of fungating malignant wounds—generalising from multiple-case study data using a system of reasoning. Int J Nurs Stud 38(5):533–545

    Article  CAS  PubMed  Google Scholar 

  19. Heisey R, Clemons M, Granek L et al (2011) Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians. Curr Oncol 18(5):e227–e237

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Gao RW, Edlund S, Yuan J (2017) Dramatic regression of a fungating breast lesion treated with radiation therapy. Cureus 9(6):e1360

    PubMed  PubMed Central  Google Scholar 

  21. El Saghir NS, Adebamowo CA, Anderson BO et al (2011) Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative. The Breast 20:S3–S11

    Article  PubMed  Google Scholar 

  22. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS (2012) Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ (Clinical research ed) 344:e2718

    PubMed  Google Scholar 

  23. Lund-Nielsen B, Müller K, Adamsen L (2005) Malignant wounds in women with breast cancer: feminine and sexual perspectives. J Clin Nurs 14(1):56–64

    Article  PubMed  Google Scholar 

  24. Maida V, Ennis M, Kuziemsky C, Trozzolo L (2009) Symptoms associated with malignant wounds: a prospective case series. J Pain Symptom Manage 37(2):206–211

    Article  PubMed  Google Scholar 

  25. Alexander S (2009) Malignant fungating wounds: key symptoms and psychosocial issues. J Wound Care 18(8):325–329

    Article  CAS  PubMed  Google Scholar 

  26. Lo SF, Hayter M, Hu WY, Tai CY, Hsu MY, Li YF (2012) Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs 68(6):1312–1321

    Article  PubMed  Google Scholar 

  27. Probst S, Arber A, Faithfull S (2013) Malignant fungating wounds–2013; the meaning of living in an unbounded body. Eur J Oncol Nurs 17(1):38–45

    Article  PubMed  Google Scholar 

  28. Grewal AS, Freedman GM, Jones JA, Taunk NK (2019) Hypofractionated radiation therapy for durable palliative treatment of bleeding, fungating breast cancers. Pract Radiat Oncol 9(2):73–76

    Article  PubMed  Google Scholar 

  29. Gunduz N, Fisher B, Saffer EA (1979) Effect of surgical removal on the growth and kinetics of residual tumor. Can Res 39(10):3861–3865

    CAS  Google Scholar 

  30. (NCCN) NCCN. Breast cancer (version 3.2019). 2019.

  31. Vempati P, Knoll MA, Dharmarajan K, Green S, Tiersten A, Bakst RL (2016) Palliation of ulcerative breast lesions with radiation. Anticancer Res 36(9):4701–4705

    Article  CAS  PubMed  Google Scholar 

  32. Petrella F, Radice D, Borri A et al (2016) Chest wall resection and reconstruction for locally recurrent breast cancer: from technical aspects to biological assessment. Surg: J Royal Colleges Surgeons Edinburgh Ireland 14(1):26–32

    Google Scholar 

  33. Pereira J, Phan T (2004) Management of bleeding in patients with advanced cancer. Oncologist 9(5):561–570

    Article  PubMed  Google Scholar 

  34. Moriarty JM, Xing M, Loh CT (2012) Particle embolization to control life-threatening hemorrhage from a fungating locally advanced breast carcinoma: a case report. J Med Case Rep 6(1):186

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ugras S, Gemignani ML, Connolly PH, Finley DJ (2015) Endovascular approach to acute hemorrhage in locally advanced breast cancer. Breast J 21(2):189–191

    Article  PubMed  Google Scholar 

  36. Aksoy Ş, Akçe B, Kılıçkesmez Ö et al (2016) Transcatheter arterial embolization for controlling severe bleeding from recurrent locally-advanced breast cancer. J Breast Health 12(3):137–140

    Article  PubMed  PubMed Central  Google Scholar 

  37. Crisera CA, Chang EI, Da Lio AL, Festekjian JH, Mehrara BJ (2011) Immediate free flap reconstruction for advanced-stage breast cancer: is it safe? Plast Reconstr Surg 128(1):32–41

    Article  CAS  PubMed  Google Scholar 

  38. Pathy NB, Verkooijen HM, Taib NA, Hartman M, Yip CH (2011) Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg 98(11):1566–1572

    Article  PubMed  Google Scholar 

  39. Sood A, Daniali LN, Rezzadeh KS, Lee ES, Keith J (2015) Management and reconstruction in the breast cancer patient with a fungating T4b tumor. Eplasty 15:e39–e39

    PubMed  PubMed Central  Google Scholar 

  40. Downes KJ, Glatt BS, Kanchwala SK et al (2005) Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma. Cancer 103(5):906–913

    Article  PubMed  Google Scholar 

  41. Badwe R, Hawaldar R, Nair N et al (2015) Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol 16(13):1380–1388

    Article  PubMed  Google Scholar 

  42. Khan SA, Zhao F, Solin LJ et al (2020) A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108). J Clin Oncol 38(18_suppl):LBA2–LBA2

    Article  Google Scholar 

  43. Lo SF, Hu WY, Hayter M, Chang SC, Hsu MY, Wu LY (2008) Experiences of living with a malignant fungating wound: a qualitative study. J Clin Nurs 17(20):2699–2708

    Article  PubMed  Google Scholar 

  44. Berry DA, Cronin KA, Plevritis SK et al (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784–1792

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors have read and approved the manuscript. Data collection and revision: AA, AE, KA, KAW, SA, MZ, OH. Conceptualization, writing: AA. Supervision and revision: MA, KAW, IH, MZ, OH. Statistical analysis: IH. Editing: OH.

Corresponding author

Correspondence to Omar Hamdy.

Ethics declarations

Ethics Approval and Consent to Participate

All procedures performed in the study involving human participants followed the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All the patients signed written consent for the surgical maneuvers for resection and reconstruction. This is a retrospective study. Consent for participation in the study itself is not applicable. Approval was obtained from the Institutional Review Board of the Faculty of Medicine, Mansoura University (MFM-IRB), under code number R.20.10.1040.

Consent for Publication

N/A.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdallah, A., Abdelwahab, K., Awny, S. et al. Fungating and Ulcerating Breast Cancer: Wound Closure Algorithm, Complications, and Survival Trends. Indian J Surg Oncol 14, 93–105 (2023). https://doi.org/10.1007/s13193-022-01602-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-022-01602-x

Keywords

Navigation